Showing results (151-160 of 180) with videos related to
Sort By:
Pageof 18
Epidemiology and Infection|September 1, 2012
Real-time modelling used for outbreak management during a cholera epidemic, Haiti, 2010-2011J Y Abrams, J R Copeland, R V Tauxe, et al.ACS Applied Materials & Interfaces|May 20, 2025
Rilpivirine Ionic Liquid Nanoemulsion Augments the Oral Bioavailability of Rilpivirine and Its Delivery to the HIV Sanctuary SitesYogesh Sutar, Joseph S Adams, Xiangmeng Wu, et al.ACS Omega|February 8, 2021
Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer TherapyHiwa K Saeed, Yogesh Sutar, Pratikkumar Patel, et al.Nanomedicine (London, England)|October 27, 2011
Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluationAbhijit A Date, Deepika Srivastava, Mangal S Nagarsenker, et al.MMWR. Morbidity and Mortality Weekly Report|October 3, 2014
Typhoid Fever surveillance and vaccine use - South-East Asia and Western Pacific regions, 2009-2013Kashmira A Date, Adwoa D Bentsi-Enchill, Kimberley K Fox, et al.Molecular Pharmaceutics|April 13, 2011
Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administrationAbhijit A Date, Mangal S Nagarsenker, Shilpa Patere, et al.Annals of Saudi Medicine|February 1, 2007
Schistosomiasis in patients in the Sultanate of OmanE M Scrimgeour, A Ahmed, J Sallam, et al.Public Health Action|May 6, 2020
Improving sputum collection processes to increase tuberculosis case finding among HIV-positive persons in BotswanaU Mathebula, C Emerson, T Agizew, et al.International Journal of Pharmaceutics|February 22, 2026
Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infectionSudipta Mallick, Pankaj Sharma, Tejabhiram Yadavalli, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 5, 2017
Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel diseaseAbhijit A Date, Rana Rais, Taarika Babu, et al.Pageof 18